In addition, Gefitinib (an EGFR-tyrosine kinase inhibitor) is among the anti-tumor drugs involved in the inhibition of the EMT process in tumor cells, with good results in clinical studies so far [83,84]. The gene discussed is EGFR; the disease is neoplasm.